BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 15486215)

  • 21. Multi-detector row CT: effect of iodine dose reduction on hepatic and vascular enhancement.
    Roos JE; Desbiolles LM; Weishaupt D; Wildermuth S; Hilfiker PR; Marincek B; Boehm T
    Rofo; 2004 Apr; 176(4):556-63. PubMed ID: 15088181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 2 contrast materials with different iodine concentrations in 3-dimensional computed tomography angiography of the hepatic artery at multi-detector-row computed tomography: a randomized study.
    Suzuki H; Shibamoto Y; Oshima H; Takeuchi M; Ito M; Hara M
    J Comput Assist Tomogr; 2007; 31(6):840-5. PubMed ID: 18043345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous contrast material administration at 16-detector row helical CT coronary angiography: test bolus versus bolus-tracking technique.
    Cademartiri F; Nieman K; van der Lugt A; Raaijmakers RH; Mollet N; Pattynama PM; de Feyter PJ; Krestin GP
    Radiology; 2004 Dec; 233(3):817-23. PubMed ID: 15516601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal multi-detector row CT: effectiveness of determining contrast medium dose on basis of body surface area.
    Onishi H; Murakami T; Kim T; Hori M; Osuga K; Tatsumi M; Higashihara H; Maeda N; Tsuboyama T; Nakamoto A; Tomoda K; Tomiyama N
    Eur J Radiol; 2011 Dec; 80(3):643-7. PubMed ID: 20864283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-detector row CT of the kidney: optimizing scan delays for bolus tracking techniques of arterial, corticomedullary, and nephrographic phases.
    Goshima S; Kanematsu M; Nishibori H; Kondo H; Tsuge Y; Yokoyama R; Miyoshi T; Onozuka M; Shiratori Y; Moriyama N; Bae KT
    Eur J Radiol; 2007 Sep; 63(3):420-6. PubMed ID: 17367973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
    Sofue K; Tsurusaki M; Kawasaki R; Fujii M; Sugimura K
    Eur J Radiol; 2011 Dec; 80(3):e237-42. PubMed ID: 21067880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic and Hepatic Contrast Enhancement During Hepatic-Arterial and Portal Venous Phase Computed Tomography Scanning: Multivariate Linear Regression Analysis Using Age, Sex, Total Body Weight, Height, and Cardiac Output.
    Masuda T; Nakaura T; Funama Y; Higaki T; Kiguchi M; Imada N; Sato T; Awai K
    J Comput Assist Tomogr; 2017; 41(2):309-314. PubMed ID: 27759599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast.
    Schueller G; Schima W; Schueller-Weidekamm C; Weber M; Stift A; Gnant M; Prokesch R
    Radiology; 2006 Nov; 241(2):441-8. PubMed ID: 16982815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast material injection for hepatic helical computed tomography. Comparative study of five protocols.
    Hoeffel C; Legmann P; Girardot C; Bunouf P; Mezzi K; Bonnin A
    Invest Radiol; 1996 Aug; 31(8):467-71. PubMed ID: 8854192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic spiral CT: reduction of dose of intravenous contrast material.
    Brink JA; Heiken JP; Forman HP; Sagel SS; Molina PL; Brown PC
    Radiology; 1995 Oct; 197(1):83-8. PubMed ID: 7568859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
    Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
    Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
    Yagyu Y; Awai K; Inoue M; Watai R; Sano T; Hasegawa H; Nishimura Y
    AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience.
    Marin D; Nelson RC; Samei E; Paulson EK; Ho LM; Boll DT; DeLong DM; Yoshizumi TT; Schindera ST
    Radiology; 2009 Jun; 251(3):771-9. PubMed ID: 19346514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simulation of aortic peak enhancement on MDCT using a contrast material flow phantom: feasibility study.
    Awai K; Hatcho A; Nakayama Y; Kusunoki S; Liu D; Hatemura M; Funama Y; Denbo M; Sato N; Yamashita Y
    AJR Am J Roentgenol; 2006 Feb; 186(2):379-85. PubMed ID: 16423942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An optimal contrast dose indicator for the determination of hepatic enhancement in abdominal multidetector computed tomography: comparison of patient attenuation indicator with total body weight and body mass index.
    Li J; Udayasankar UK; Tang X; Carew J; Toth TL; Small WC
    J Comput Assist Tomogr; 2010; 34(6):874-8. PubMed ID: 21084903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal contrast medium injection protocols for the depiction of the Adamkiewicz artery using 64-detector CT angiography.
    Nakayama Y; Awai K; Yanaga Y; Nakaura T; Funama Y; Hirai T; Yamashita Y
    Clin Radiol; 2008 Aug; 63(8):880-7. PubMed ID: 18625352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.
    Gordic S; Puippe GD; Krauss B; Klotz E; Desbiolles L; Lesurtel M; Müllhaupt B; Pfammatter T; Alkadhi H
    Radiology; 2016 Jul; 280(1):78-87. PubMed ID: 26824712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic helical CT: contrast material injection protocol.
    Foley WD; Hoffmann RG; Quiroz FA; Kahn CE; Perret RS
    Radiology; 1994 Aug; 192(2):367-71. PubMed ID: 8029399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.